Mgr. Aneta Ledererová
Office: bud. E35/141
Kamenice 753/5
625 00 Brno
| Phone: | +420 549 49 5875 |
|---|---|
| E‑mail: |
|
Publications
Total number of publications: 16
2020
-
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells
Plos one, year: 2020, volume: 15, edition: 3, DOI
-
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
Journal for ImmunoTherapy of Cancer, year: 2020, volume: 8, edition: 1, DOI
2019
-
Elucidation of factors enhancing the expression of CD20 and thereby efficiency of CD20 monoclonal antibodies through epigenetic drug screening of resistant CLL cells
Year: 2019, type: Conference abstract
-
Epigenetic drug screen of a CD20-low expressing cell line revealed an unexpected role of Aurora kinase inhibitors in CD20 expression.
Year: 2019, type: Conference abstract
-
Epigenetic drug screen of CD20-low expressing cell line revealed possible treatment target.
Year: 2019, type: Conference abstract
-
Epigenetic drug screen on CD20 immunotherapy resistant cells revealed possible role of Aurora kinase inhibitors in CD20 expression regulation.
Year: 2019, type: Conference abstract
2018
-
Epigenetic drug screen of rituximab resistant cell line revealed possible treatment targets
Year: 2018, type: Conference abstract
-
Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies
Year: 2018, type: Conference abstract
-
Epigenetic drug screen on rituximab-resistant cells revealed in unexpected role of Aurora kinase inhibitors in CD20 expression
Year: 2018, type: Conference abstract
-
Epigenetický screening buněk rezistentních k rituximabu odhalil možnou roli inhibitorů Aurora kináz v regulaci exprese CD20
Year: 2018, type: Conference abstract